Memic Innovative Surgery

Headquarters: Tel Aviv, Israel

Investor Relations: Greg Chodaczek / Gilmartin Group / greg@gilmartinir.com / 347-620-7010

Description

Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpass today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis® surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation. In addition to these features, the system will be sold at a significantly lower price compared to other marketed robotic surgery systems potentially allowing more medical facilities including hospitals and ambulatory surgical centers to access and adopt surgical robotics. Beyond the current applications for transvaginal procedures, Memic is further developing this technology to explore use in abdominal single and multi-port surgery, as well as other transluminal indications.

Industry

Medical Devices

Year Founded

2013

Website

https://memicmed.com/

Ownership

Private

Chief Executive Officer

Chairman of the Board

Chief Financial Officer

Insider Ownership

Key Investors

Employee Count

Trailing Revenues

Trailing Operating Profits

Trailing Net Income

Most Recent Raise (Date)

Round

Capital Raised

Auditors

Investment Bankers

Law Firm

In the CEOs Own Words

Corporate Mission

Proudest Accomplishment

Next Milestone

Geographic Markets Served

Growth Drivers

Growth Headwinds

Indicia of Customer Satisfaction

Scalability

Workforce

Focus of Recruitment

Research and Development

Patent Count

Economic Sensitivity

Unique Metrics

Greatest Concern

Company Reports and Communications

Company Press Releases

Reports

Podcasts

Open Questions to Management

Chatboard